Pfizer has announced its plan to invest $100 million in its Sanford, North Carolina gene therapy facility, adding 40 jobs to a workforce of about 450 workers.
According to Pfizer, the expansion, which initial hiring has just gone underway, will grow the clinical and commercial manufacturing facility. In 2016, Pfizer acquired Chapel Hill biotech company Bamboo Therapeutics in a $645 million deal.
Pfizer has committed $4 million in North Carolina universities to support postdoctoral fellowships related to gene therapy research.
Pfizer has also been awarded a $250,000 economic development incentive grant from the One North Carolina Fund to support the expansion.
Read the Triangle Business Journal report